多嚢胞性卵巣症候群（PCOS）治療薬の世界市場2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global Polycystic Ovary Syndrome (PCOS) Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：MRC2012A7253 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。多嚢胞性卵巣症候群（PCOS）治療薬の種類別市場規模（経口避妊薬、抗アンドロゲン剤、インスリン感作剤、抗うつ剤、抗肥満剤）、用途別市場規模（病院、診療所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Bristol Myers Squibb Co.、Addex Therapeutics Ltd.、Novartis AG、AstraZeneca plc.、Teva Pharmaceutical Industries Limited、Crinetics Pharmaceuticals, Inc.、Merck KGaA、BIOCAD、Ferring Pharmaceuticals, Inc.、 ・地域別グローバル市場分析 2015年-2020年 ・多嚢胞性卵巣症候群（PCOS）治療薬の北米市場（アメリカ、カナダ、メキシコ） ・多嚢胞性卵巣症候群（PCOS）治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・多嚢胞性卵巣症候群（PCOS）治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・多嚢胞性卵巣症候群（PCOS）治療薬の南米市場（ブラジル、アルゼンチン） ・多嚢胞性卵巣症候群（PCOS）治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口避妊薬、抗アンドロゲン剤、インスリン感作剤、抗うつ剤、抗肥満剤 ・用途別分析：病院、診療所 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Polycystic Ovary Syndrome (PCOS) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Polycystic Ovary Syndrome (PCOS) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Polycystic Ovary Syndrome (PCOS) Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Polycystic Ovary Syndrome (PCOS) Drugs market has been segmented into
Oral Contraceptives
Antiandrogens
Insulin-sensitizing Agent
Antidepressant
Anti-obesity

By Application, Polycystic Ovary Syndrome (PCOS) Drugs has been segmented into:
Hospital
Clinic

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Polycystic Ovary Syndrome (PCOS) Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Polycystic Ovary Syndrome (PCOS) Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Polycystic Ovary Syndrome (PCOS) Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Polycystic Ovary Syndrome (PCOS) Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Polycystic Ovary Syndrome (PCOS) Drugs Market Share Analysis
Polycystic Ovary Syndrome (PCOS) Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Polycystic Ovary Syndrome (PCOS) Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Polycystic Ovary Syndrome (PCOS) Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Polycystic Ovary Syndrome (PCOS) Drugs are:
Sanofi
Bristol Myers Squibb Co.
Addex Therapeutics Ltd.
Novartis AG
AstraZeneca plc.
Teva Pharmaceutical Industries Limited
Crinetics Pharmaceuticals, Inc.
Merck KGaA
BIOCAD
Ferring Pharmaceuticals, Inc.

Among other players domestic and global, Polycystic Ovary Syndrome (PCOS) Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Polycystic Ovary Syndrome (PCOS) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Polycystic Ovary Syndrome (PCOS) Drugs, with price, sales, revenue and global market share of Polycystic Ovary Syndrome (PCOS) Drugs in 2018 and 2019.
Chapter 3, the Polycystic Ovary Syndrome (PCOS) Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Polycystic Ovary Syndrome (PCOS) Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Polycystic Ovary Syndrome (PCOS) Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Polycystic Ovary Syndrome (PCOS) Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Polycystic Ovary Syndrome (PCOS) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Oral Contraceptives
1.2.3 Antiandrogens
1.2.4 Insulin-sensitizing Agent
1.2.5 Antidepressant
1.2.6 Anti-obesity
1.3 Market Analysis by Application
1.3.1 Overview: Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.4 Overview of Global Polycystic Ovary Syndrome (PCOS) Drugs Market
1.4.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol Myers Squibb Co.
2.2.1 Bristol Myers Squibb Co. Details
2.2.2 Bristol Myers Squibb Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bristol Myers Squibb Co. SWOT Analysis
2.2.4 Bristol Myers Squibb Co. Product and Services
2.2.5 Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Addex Therapeutics Ltd.
2.3.1 Addex Therapeutics Ltd. Details
2.3.2 Addex Therapeutics Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Addex Therapeutics Ltd. SWOT Analysis
2.3.4 Addex Therapeutics Ltd. Product and Services
2.3.5 Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis AG SWOT Analysis
2.4.4 Novartis AG Product and Services
2.4.5 Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca plc.
2.5.1 AstraZeneca plc. Details
2.5.2 AstraZeneca plc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AstraZeneca plc. SWOT Analysis
2.5.4 AstraZeneca plc. Product and Services
2.5.5 AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teva Pharmaceutical Industries Limited
2.6.1 Teva Pharmaceutical Industries Limited Details
2.6.2 Teva Pharmaceutical Industries Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teva Pharmaceutical Industries Limited SWOT Analysis
2.6.4 Teva Pharmaceutical Industries Limited Product and Services
2.6.5 Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Crinetics Pharmaceuticals, Inc.
2.7.1 Crinetics Pharmaceuticals, Inc. Details
2.7.2 Crinetics Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Crinetics Pharmaceuticals, Inc. SWOT Analysis
2.7.4 Crinetics Pharmaceuticals, Inc. Product and Services
2.7.5 Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck KGaA
2.8.1 Merck KGaA Details
2.8.2 Merck KGaA Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck KGaA SWOT Analysis
2.8.4 Merck KGaA Product and Services
2.8.5 Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 BIOCAD
2.9.1 BIOCAD Details
2.9.2 BIOCAD Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BIOCAD SWOT Analysis
2.9.4 BIOCAD Product and Services
2.9.5 BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ferring Pharmaceuticals, Inc.
2.10.1 Ferring Pharmaceuticals, Inc. Details
2.10.2 Ferring Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Ferring Pharmaceuticals, Inc. SWOT Analysis
2.10.4 Ferring Pharmaceuticals, Inc. Product and Services
2.10.5 Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Polycystic Ovary Syndrome (PCOS) Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Polycystic Ovary Syndrome (PCOS) Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
4.5 South America Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Polycystic Ovary Syndrome (PCOS) Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Polycystic Ovary Syndrome (PCOS) Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Polycystic Ovary Syndrome (PCOS) Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Polycystic Ovary Syndrome (PCOS) Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
6.3 UK Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
6.4 France Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
7.5 India Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Polycystic Ovary Syndrome (PCOS) Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Polycystic Ovary Syndrome (PCOS) Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Polycystic Ovary Syndrome (PCOS) Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Polycystic Ovary Syndrome (PCOS) Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Polycystic Ovary Syndrome (PCOS) Drugs Price by Type (2015-2020)
11 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Segment by Application
11.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Application (2015-2020)
11.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Polycystic Ovary Syndrome (PCOS) Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast (2021-2025)
12.2.2 Europe Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast (2021-2025)
12.2.4 South America Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast (2021-2025)
12.3 Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Share Forecast by Type (2021-2025)
12.4 Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Polycystic Ovary Syndrome (PCOS) Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Polycystic Ovary Syndrome (PCOS) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Major Business
Table 9. Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Product and Services
Table 12. Sanofi Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bristol Myers Squibb Co. Basic Information, Manufacturing Base and Competitors
Table 14. Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Major Business
Table 15. Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Bristol Myers Squibb Co. SWOT Analysis
Table 17. Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Product and Services
Table 18. Bristol Myers Squibb Co. Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Addex Therapeutics Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Major Business
Table 21. Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Addex Therapeutics Ltd. SWOT Analysis
Table 23. Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Product and Services
Table 24. Addex Therapeutics Ltd. Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 26. Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Major Business
Table 27. Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Novartis AG SWOT Analysis
Table 29. Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Product and Services
Table 30. Novartis AG Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. AstraZeneca plc. Basic Information, Manufacturing Base and Competitors
Table 32. AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Major Business
Table 33. AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Total Revenue (USD Million) (2017-2018)
Table 34. AstraZeneca plc. SWOT Analysis
Table 35. AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Product and Services
Table 36. AstraZeneca plc. Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Teva Pharmaceutical Industries Limited Basic Information, Manufacturing Base and Competitors
Table 38. Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Major Business
Table 39. Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Teva Pharmaceutical Industries Limited SWOT Analysis
Table 41. Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Product and Services
Table 42. Teva Pharmaceutical Industries Limited Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Crinetics Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Major Business
Table 45. Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Crinetics Pharmaceuticals, Inc. SWOT Analysis
Table 47. Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Product and Services
Table 48. Crinetics Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 50. Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Major Business
Table 51. Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Merck KGaA SWOT Analysis
Table 53. Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Product and Services
Table 54. Merck KGaA Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. BIOCAD Basic Information, Manufacturing Base and Competitors
Table 56. BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Major Business
Table 57. BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Total Revenue (USD Million) (2017-2018)
Table 58. BIOCAD SWOT Analysis
Table 59. BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Product and Services
Table 60. BIOCAD Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Ferring Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Major Business
Table 63. Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Ferring Pharmaceuticals, Inc. SWOT Analysis
Table 65. Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Product and Services
Table 66. Ferring Pharmaceuticals, Inc. Polycystic Ovary Syndrome (PCOS) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 68. Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales by Regions (2015-2020) (K Pcs)
Table 70. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Regions (2015-2020)
Table 71. Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Polycystic Ovary Syndrome (PCOS) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 73. North America Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Countries (2015-2020)
Table 74. North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Countries (2015-2020)
Table 76. Europe Polycystic Ovary Syndrome (PCOS) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 77. Europe Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Countries (2015-2020)
Table 78. Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Sales by Regions (2015-2020) (K Pcs)
Table 80. Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Polycystic Ovary Syndrome (PCOS) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 83. South America Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Countries (2015-2020)
Table 84. South America Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Polycystic Ovary Syndrome (PCOS) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 87. Middle East & Africa Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Countries (2015-2020)
Table 90. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales by Type (2015-2020) (K Pcs)
Table 91. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Share by Type (2015-2020)
Table 92. Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue by Type (2015-2020) (USD Million)
Table 93. Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Share by Type (2015-2020)
Table 94. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales by Application (2015-2020) (K Pcs)
Table 95. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Share by Application (2015-2020)
Table 96. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 97. Global Polycystic Ovary Syndrome (PCOS) Drugs Market Share Forecast by Regions (2021-2025)
Table 98. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 99. Global Polycystic Ovary Syndrome (PCOS) Drugs Market Share Forecast by Type (2021-2025)
Table 100. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Forecast by Application (2021-2025)
Table 101. Global Polycystic Ovary Syndrome (PCOS) Drugs Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Polycystic Ovary Syndrome (PCOS) Drugs Picture
Figure 2. Global Sales Market Share of Polycystic Ovary Syndrome (PCOS) Drugs by Type in 2019
Figure 3. Oral Contraceptives Picture
Figure 4. Antiandrogens Picture
Figure 5. Insulin-sensitizing Agent Picture
Figure 6. Antidepressant Picture
Figure 7. Anti-obesity Picture
Figure 8. Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Global Polycystic Ovary Syndrome (PCOS) Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Polycystic Ovary Syndrome (PCOS) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Manufacturer in 2019
Figure 32. Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Polycystic Ovary Syndrome (PCOS) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Polycystic Ovary Syndrome (PCOS) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 37. Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Regions (2015-2020)
Figure 39. Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Regions in 2018
Figure 40. North America Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
Figure 41. Europe Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
Figure 43. South America Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020)
Figure 45. North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Countries (2015-2020)
Figure 47. North America Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Countries in 2018
Figure 48. North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Countries in 2018
Figure 50. United States Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Canada Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Mexico Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Countries in 2019
Figure 56. Germany Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. UK Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. France Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Regions 2019
Figure 64. China Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Korea Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. India Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Southeast Asia Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. South America Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Countries in 2019
Figure 71. South America Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Countries in 2019
Figure 72. Brazil Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Argentina Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Middle East and Africa Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Polycystic Ovary Syndrome (PCOS) Drugs Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Polycystic Ovary Syndrome (PCOS) Drugs Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Egypt Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Turkey Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. South Africa Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Global Polycystic Ovary Syndrome (PCOS) Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 83. Global Polycystic Ovary Syndrome (PCOS) Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 85. Europe Sales Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 86. Asia-Pacific Sales Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 87. South America Sales Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 88. Middle East & Africa Sales Polycystic Ovary Syndrome (PCOS) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel

---